+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Drug and alcohol treatment providers' views about the disease model of addiction and its impact on clinical practice: A systematic review



Drug and alcohol treatment providers' views about the disease model of addiction and its impact on clinical practice: A systematic review



Drug and Alcohol Review 37(6): 697-720



Addiction treatment providers' views about the disease model of addiction (DMA), and their contemporary views about the brain disease model of addiction (BDMA), remain an understudied area. We systematically reviewed treatment providers' attitudes about the DMA/BDMA, examined factors associated with positive or negative attitudes and assessed their views on the potential clinical impact of both models. Pubmed, EMBASE, PsycINFO, CINAHL Plus and Sociological Abstracts were systematically searched. Original papers on treatment providers' views about the DMA/BDMA and its clinical impact were included. Studies focussing on tobacco, behavioural addictions or non-Western populations were excluded. The 34 included studies were predominantly quantitative and conducted in the USA. Among mixed findings of treatment providers' support for the DMA, strong validity studies indicated treatment providers supported the disease concept and moral, free-will or social models simultaneously. Support for the DMA was positively associated with treatment providers' age, year of qualification, certification status, religious beliefs, being in recovery and Alcoholics Anonymous attendance. Greater education was negatively associated with DMA support. Treatment providers identified potential positive (e.g. reduced stigma) and negative (e.g. increased sense of helplessness) impacts of the DMA on client behaviour. The review suggests treatment providers may endorse disease and other models while strategically deploying the DMA for presumed therapeutic benefits. Varying DMA support across workforces indicated service users may experience multiple and potentially contradictory explanations of addiction. Future policy development will benefit by considering how treatment providers adopt disease concepts in practice.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 058893500

Download citation: RISBibTeXText

PMID: 29239048

DOI: 10.1111/dar.12632


Related references

Methadone treatment providers' views of drug court policy and practice: a case study of New York State. Harm Reduction Journal 10: 35, 2013

A persistent contradiction in treatment providers' views on addiction. Drug and Alcohol Review 37(6): 723-725, 2018

The current perspective of neuromodulation techniques in the treatment of alcohol addiction: a systematic review. Psychiatria Danubina 24(Suppl. 1): S14-S20, 2012

Practitioner review: evidence-based practice guidelines on alcohol and drug misuse among adolescents: a systematic review. Journal of Child Psychology and Psychiatry, and Allied Disciplines 55(1): 3-21, 2014

An argument against the implementation of an 'overarching universal addiction model' in alcohol and other drug treatment. Drug and Alcohol Review 37(6): 721-722, 2018

Predictors of addiction treatment providers' beliefs in the disease and choice models of addiction. Journal of Substance Abuse Treatment 40(2): 150-164, 2011

The impact of chronic pain on opioid addiction treatment: a systematic review protocol. Systematic Reviews 4: 49, 2015

Systematic Review of Occupational Therapy in the Treatment of Addiction: Models, Practice, and Qualitative and Quantitative Research. American Journal of Occupational Therapy 71(5): 7105100030p1-7105100030p11, 2017

Economic and other views of addiction: implications for the choice of alcohol, tobacco and drug policies. Drug and Alcohol Review 15(4): 357-368, 1996

The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. American Journal on Addictions 24(1): 15-23, 2015

The role of opioidergic genes in the treatment outcome of drug addiction pharmacotherapy: A systematic review. American Journal on Addictions, 2014

Heminevrin (chlormethiazole). A new drug for the treatment of acute complications of alcohol addiction and related states. Review. Ugeskrift for Laeger 128(34): 969-973, 1966

Adoption of a novel surgical innovation into clinical practice: protocol for a qualitative systematic review examining surgeon views. Bmj Open 8(4): E020486, 2018

Impact of addiction severity and psychiatric comorbidity on the quality of life of alcohol-, drug- and dual-dependent persons in residential treatment. European Addiction Research 19(4): 173-183, 2014

Changing of students' views toward addiction by self-introduced drug abusers and their families (addiction against addiction). Medical Journal of Islamic Re ic of Iran 17(4): 297-300, 2004